Harnessing Technology to Optimize Pharmacovigilance - Qinecsa

Harnessing Technology to Optimize Pharmacovigilance

We’re proud to be featured in Applied Clinical Trials’ latest article spotlighting the future of pharmacovigilance: “Harnessing Technology and Adopting Unified Approaches to Optimize Pharmacovigilance Activities.”

In this thought leadership piece, our VP of Product, Daniel O’keeffe, explores how unified, digital-first approaches are reshaping global PV – putting patient safety front and center while reducing complexity and cost.

From persona based, fully configurable, digital tools, to AI-powered document ingestion, discover how Qinecsa ticks all the boxes for modern pharmacovigilance intake.

Read Article

Recent Articles

The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?

Embracing quantitative signal detection methods as a smaller MAH

Real-Time Safety Signals Drive Continuous PV Insight

From Complaint Handling to Active Surveillance

Continuous Safety Surveillance for Medical Devices

Are patient outcomes getting lost in safety data complexity?

Previous Fit-for-Purpose Signal Detection Solutions for Pharmacovigilance

Next Press Release: Qinecsa acquires Commonwealth Informatics